{"id":94,"date":"2026-02-03T18:41:30","date_gmt":"2026-02-03T18:41:30","guid":{"rendered":"http:\/\/timothypowell"},"modified":"2026-03-18T09:28:13","modified_gmt":"2026-03-18T09:28:13","slug":"the-gap-between-a-treatment-that-exists-and-a-patient-who-can-access-it-is-often-a-communications-problem","status":"publish","type":"post","link":"https:\/\/leahluong.com\/wordpress\/the-gap-between-a-treatment-that-exists-and-a-patient-who-can-access-it-is-often-a-communications-problem\/","title":{"rendered":"The Gap Between a Treatment That Exists and a Patient Who Can Access It Is Often a Communications Problem"},"content":{"rendered":"\n<p>Imagine this: A patient has just received a diagnosis. Their physician has identified the right treatment. The prescription has been written. And then \u2014 nothing. Days pass. Sometimes weeks. The patient calls the pharmacy, calls the doctor&#8217;s office, calls the insurance company. No one has a clear answer. The medication exists. The prescription exists. The patient exists. And yet somehow, the path between all three has collapsed.<\/p>\n\n\n\n<p>This is not a rare edge case. It is one of the most common and costly failures in the American healthcare system. And while it is often framed as a policy problem or an administrative problem, at its core it is frequently a communications problem.<\/p>\n\n\n\n<p><strong>The Prior Authorization Bottleneck<\/strong><\/p>\n\n\n\n<p>Prior authorization (the process by which insurers require advance approval before covering certain treatments) was designed to ensure medical necessity and cost-effectiveness. In theory it is a reasonable safeguard. In practice it has become one of the most significant barriers between patients and the care their physicians have prescribed.<\/p>\n\n\n\n<p>The communications failures within this process are well documented. Physicians often do not know exactly what clinical documentation a specific insurer requires for a specific drug, leading to incomplete submissions and automatic denials. Coverage criteria change frequently and are rarely communicated clearly to providers. And perhaps most critically, patients often learn that their prescription requires prior authorization only when they arrive at the pharmacy to pick it up. By that point days or weeks may have already passed since the prescription was written.<\/p>\n\n\n\n<p>That moment at the pharmacy counter is a communications failure with a human face. The patient was never told. The system assumed someone else would explain it. No one did.<\/p>\n\n\n\n<p><strong>Where HUB Services Come In \u2014 And Where They Fall Short<\/strong><\/p>\n\n\n\n<p>Pharmaceutical manufacturers have responded to this access gap by building HUB services\u2014centralized patient support programs designed to navigate the administrative complexity on behalf of patients and providers. A well-functioning HUB handles benefit investigations, prior authorization submissions, insurance appeals, copay assistance enrollment, and specialty pharmacy coordination. For patients with complex, high-cost conditions\u2014cancer, rare diseases, autoimmune disorders\u2014a HUB can be the difference between starting treatment in weeks versus months.<\/p>\n\n\n\n<p>But HUB services are only as effective as their communications infrastructure. A program that exists but that patients and providers don&#8217;t know how to access has already failed. A case manager who speaks in clinical or administrative language to a patient who is frightened and overwhelmed has failed at the human layer. A support program that generates touchpoints without generating understanding is performing access rather than enabling it.<\/p>\n\n\n\n<p>The question is not whether the program exists. The question is whether the right person receives the right information in the right language at the right moment in their journey.<\/p>\n\n\n\n<p><strong>The Specialty Pharmacy Final Mile<\/strong><\/p>\n\n\n\n<p>For patients who make it through prior authorization and into a HUB-supported access pathway, specialty pharmacy is often the final \u2014 and sometimes most fragile \u2014 link in the chain. Specialty pharmacies serve patients with chronic, rare, or complex conditions requiring high-cost medications that need specialized handling, storage, and clinical support. Unlike a retail pharmacy visit, the specialty pharmacy relationship is ongoing, high-touch, and deeply consequential for adherence and outcomes.<\/p>\n\n\n\n<p>This is where communications must be most precise and most human simultaneously. A patient managing a complex condition, navigating financial assistance programs, learning to self-administer a specialty medication \u2014 that patient needs clear, consistent, compassionate communication from every point in the system. Fragmented messaging, inconsistent information across channels, or clinical language that assumes too much literacy or too much prior knowledge can derail adherence even after every administrative hurdle has been cleared.<\/p>\n\n\n\n<p><strong>The Communications Opportunity<\/strong><\/p>\n\n\n\n<p>The good news is that the access gap is not inevitable. It is addressable. And communications strategy is one of the most powerful and underutilized tools for addressing it.<\/p>\n\n\n\n<p>Clearer prior authorization guidance for providers reduces incomplete submissions. Proactive patient notification earlier in the prescription journey prevents the pharmacy counter moment. HUB service outreach designed around plain language and health literacy principles reaches more patients more effectively. Specialty pharmacy communications that treat patients as whole people navigating complex circumstances, not just cases to be managed, improve adherence and outcomes.<\/p>\n\n\n\n<p>The treatments exist. The support programs exist. The gap between them and the patients who need them is often a matter of whether the right words reach the right person at the right time.<\/p>\n\n\n\n<p>That gap is a communications problem, and communications problems have communications solutions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is not a rare edge case. It is one of the most common and costly failures in the American healthcare system. And while it is often framed as a policy problem or an administrative problem, at its core it is frequently a communications problem.<\/p>\n","protected":false},"author":1,"featured_media":84,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-94","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/posts\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":3,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/posts\/94\/revisions"}],"predecessor-version":[{"id":541,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/posts\/94\/revisions\/541"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/media\/84"}],"wp:attachment":[{"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/media?parent=94"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/categories?post=94"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leahluong.com\/wordpress\/wp-json\/wp\/v2\/tags?post=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}